橙帆医药(VelaVigo Cayman Limited) Mediaroom - PR Newswire APAC

Search

橙帆医药(VelaVigo Cayman Limited)

Latest News

VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate

SHANGHAI and BOSTON, Nov. 18, 2024 /PRNewswire/ -- VelaVigo Cayman Limited (VelaVigo), a biotech co...

2024-11-18 21:01 1354